JP Morgan Chase’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-5,069
| Closed | -$13K | – | 6022 |
|
|
2020
Q2 | $13K | Buy |
+5,069
| New | +$9.61K | ﹤0.01% | 5102 |
|
|
2019
Q4 | – | Sell |
-6,068
| Closed | -$32K | – | 6035 |
|
|
2019
Q3 | $32K | Buy |
6,068
+247
| +4% | +$1.65K | ﹤0.01% | 5310 |
|
|
2019
Q2 | $56K | Buy |
5,821
+5,177
| +804% | +$95.3K | ﹤0.01% | 5129 |
|
|
2019
Q1 | $17K | Sell |
644
-30,760
| -98% | -$783K | ﹤0.01% | 5442 |
|
|
2018
Q4 | $709K | Buy |
31,404
+1,160
| +4% | +$45.4K | ﹤0.01% | 3946 |
|
|
2018
Q3 | $1.67M | Sell |
30,244
-831
| -3% | -$53.1K | ﹤0.01% | 3579 |
|
|
2018
Q2 | $2.22M | Buy |
31,075
+24,289
| +358% | +$1.71M | ﹤0.01% | 3342 |
|
|
2018
Q1 | $417K | Sell |
6,786
-51,633
| -88% | -$4.53M | ﹤0.01% | 4081 |
|
|
2017
Q4 | $7.36M | Sell |
58,419
-1,546
| -3% | -$198K | ﹤0.01% | 2363 |
|
|
2017
Q3 | $7.92M | Buy |
+59,965
| New | +$8.02M | ﹤0.01% | 2182 |
|
|
2017
Q2 | – | Sell |
-1,156
| Closed | -$212K | – | 5358 |
|
|
2017
Q1 | $212K | Buy |
1,156
+542
| +88% | +$60.8K | ﹤0.01% | 4050 |
|
|
2016
Q4 | $49K | Buy |
614
+561
| +1,058% | +$44.4K | ﹤0.01% | 4556 |
|
|
2016
Q3 | $4K | Sell |
53
-51
| -49% | -$4.09K | ﹤0.01% | 4393 |
|
|
2016
Q2 | $9K | Buy |
104
+95
| +1,056% | +$8.7K | ﹤0.01% | 4363 |
|
|
2016
Q1 | $1K | Sell |
9
-1
| -10% | -$100 | ﹤0.01% | 4600 |
|
|
2015
Q4 | $3K | Buy |
+10
| New | +$2K | ﹤0.01% | 4475 |
|
|
2014
Q2 | – | Sell |
-1,470
| Closed | -$320K | – | 3665 |
|
|
2014
Q1 | $320K | Buy |
+1,470
| New | +$410K | ﹤0.01% | 3269 |
|
JP Morgan Chase's TTPH Position: Q3 2020 in Review
JP Morgan Chase sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 5,069 shares — an estimated $13K sold.
JP Morgan Chase first reported a position in TTPH in Q1 2014 and held it in 17 quarters. The position peaked at $7.92M in Q3 2017. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.
- JP Morgan Chase reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- JP Morgan Chase sold 5,069 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $13K.
- JP Morgan Chase first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2014 and held it in 17 quarters.
- JP Morgan Chase's Tetraphase Pharmaceuticals, Inc. position peaked at $7.92M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.
Based on JP Morgan Chase's 13F filing for Q3 2020, filed 12 Nov 2020.